Department: Genetics

B

• 
  Bagley, Steven Christopher
  Academic Appointments Sr Research Engineer,  Genetics
  
• 
  Baker, Julie 
  Academic Appointments Associate Professor,  Genetics
  Member,  Bio-X
  
  Research Interest

  Our laboratory is focused on identifying proteins based upon their ability to alter a variety of cell fate decisions - including mesodermal, endodermal, neural, endothelial, and somitic - within the vertebrate embryo.
• 
  Barna, Maria 
  Academic Appointments Assistant Professor,  Genetics
  Assistant Professor,  Developmental Biology
  
  Research Interest

  Our laboratory investigates how complex, elaborately patterned tissues form during vertebrate embryonic development. In particular we aim to add a new dimension to our understanding of how cells “know” where to go, when to move, and differentiate. We combine classical embryology with state-of-the-art biochemistry, imaging, and genomics. Major research areas include delineating the translational regulatory code of the mammalian genome and cutting-edge imaging of tissue patterning.
• 
  Barsh, Gregory 
  Academic Appointments Professor Emeritus,  Genetics
  Emeritus Faculty, Acad Council,  Genetics
  Member,  Bio-X
  
  Clinical Focus

  • Cancer Genetics
  • Clinical Genetics
  Research Interest

  Genetics of color variation
• 
  Benayoun, Berenice 
  Academic Appointments Postdoctoral Research fellow, Genetics
  
• 
  Booth, Lauren Nicole
  Academic Appointments Postdoctoral Research fellow, Genetics
  
• 
  Boyle, Sean Michael
  Academic Appointments Postdoctoral Research fellow, Genetics
  
• 
  Boyle, Alan Patrick
  Academic Appointments Postdoctoral Research fellow, Genetics
  
• 
  Brahic, Michel 
  Academic Appointments Consulting Professor,  Genetics
  
  Research Interest

  The lesions of Parkinson's disease (PD) spread within the central nervous system (CNS) with characteristics of prion diseases. The prion in this case is a misfolded form of alpha-synuclein. We are investigating the mechanism of spread on alpha-synuclein prions with a special attention to axonal transport and transfer of prions between neurons. Understanding these pathways could lead to using drugs to slow down or halt disease progression.
• 
  Brunet, Anne 
  Academic Appointments Associate Professor,  Genetics
  Member,  Stanford Cancer Institute
  Member,  Bio-X
  
  Research Interest

  Our lab studies the molecular basis of longevity. We are interested in the mechanism of action of known longevity genes, including FOXO and SIRT, in the mammalian nervous system. We are particularly interested in the role of these longevity genes in neural stem cells. We are also discovering novel genes and processes involved in aging using two short-lived model systems, the invertebrate C. elegans and an extremely short-lived vertebrate, the African killifish N. furzeri.
• 
  Buenrostro, Jason Daniel
  Academic Appointments Ph.D. Student in Genetics, admitted Autumn 2011
  
  Research Interest

  Please visit my personal page at: https://sites.google.com/site/jdbuenrostro/
• 
  Bustamante, Carlos D.
  Academic Appointments Professor,  Genetics
  Member,  Bio-X
  Professor (By courtesy),  Biology (School of Humanities and Sciences)
  
  Research Interest

  My research focuses on analyzing genome wide patterns of variation within and between species to address fundamental questions in biology, anthropology, and medicine. My group works on a variety of organisms and model systems ranging from humans and other primates to domesticated plant and animals. Much of our research is at the interface of computational biology, mathematical genetics, and evolutionary genomics.
• 
  Butte, Atul J
  Academic Appointments Associate Professor,  Pediatrics - Systems Medicine
  Member,  Child Health Research Institute
  Member,  Stanford Cancer Institute
  Member,  Bio-X
  Associate Professor,  Genetics
  Associate Professor (By courtesy),  Computer Science
  Associate Professor (By courtesy),  Medicine - Immunology & Rheumatology
  
  Research Interest

  The Butte Lab at Stanford builds and applies tools that convert more than 300 billion points of molecular, clinical, and epidemiological data -- measured by researchers and clinicians over the past decade -- into diagnostics, therapeutics, and new insights into disease.